Literature DB >> 16982857

Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response.

Meixiao Long1, Adam J Adler.   

Abstract

IL-2 is expressed predominantly by activated T cells, and regulates T cell function by activating, via its receptor, the latent transcription factor STAT5. This signaling can occur in either a paracrine (between cells) or an autocrine (same cell) manner, although the kinetics by which these two signaling modes operate during in vivo T cell responses are unknown. In the current study, IL-2 expression and signaling in a clonotypic population of antiviral CD4+ T cells was analyzed by flow cytometry during the initial 24 h of priming. IL-2 expression and STAT5 activation peaked in parallel, but surprisingly, were almost completely mutually exclusive. Thus, only paracrine IL-2 signaling could be observed. As an additional indication of the efficiency of paracrine IL-2 signaling, polyclonal CD4+CD25+Foxp3+ regulatory T cells displayed detectable STAT5 activation under steady-state conditions, which was strongly enhanced by neighboring IL-2-expressing antiviral CD4 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982857      PMCID: PMC2845921          DOI: 10.4049/jimmunol.177.7.4257

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses.

Authors:  Warren N D'Souza; Kimberly S Schluns; David Masopust; Leo Lefrançois
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

2.  CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement.

Authors:  Amy D Higgins; Marianne A Mihalyo; Patrick W McGary; Adam J Adler
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

3.  T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation.

Authors:  Joseph R Maxwell; Robert J Rossi; Stephen J McSorley; Anthony T Vella
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

Review 4.  Control of T cell viability.

Authors:  Philippa Marrack; John Kappler
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 5.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 7.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

8.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

9.  Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Authors:  Gláucia C Furtado; Maria A Curotto de Lafaille; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

10.  CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.

Authors:  Susmit Suvas; Uday Kumaraguru; Christopher D Pack; Sujin Lee; Barry T Rouse
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  28 in total

1.  Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.

Authors:  Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Harry Z Qui; David J Zammit; Leo Lefrancois; Adam J Adler
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

2.  A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction.

Authors:  Catherine A Sabatos; Junsang Doh; Sumone Chakravarti; Rachel S Friedman; Priya G Pandurangi; Aaron J Tooley; Matthew F Krummel
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

3.  Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells.

Authors:  Daniel DiToro; Colleen J Winstead; Duy Pham; Steven Witte; Rakieb Andargachew; Jeffrey R Singer; C Garrett Wilson; Carlene L Zindl; Rita J Luther; Daniel J Silberger; Benjamin T Weaver; E Motunrayo Kolawole; Ryan J Martinez; Henrietta Turner; Robin D Hatton; James J Moon; Sing Sing Way; Brian D Evavold; Casey T Weaver
Journal:  Science       Date:  2018-09-14       Impact factor: 47.728

4.  An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.

Authors:  Payal Mittal; Rebecca Abblett; Joseph M Ryan; Adam T Hagymasi; Archibald Agyekum-Yamoah; Julia Svedova; Steven L Reiner; Marie-Clare St Rose; Matthew P Hanley; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2018-01-05       Impact factor: 5.422

5.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

6.  Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation.

Authors:  Matthew F Krummel; Jagdish N Mahale; Lion F K Uhl; Emily A Hardison; Adriana M Mujal; Julie M Mazet; Robert J Weber; Zev J Gartner; Audrey Gérard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

7.  DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development.

Authors:  Ching-Yu Huang; Yu-Chun Lin; Wan-Yi Hsiao; Fang-Hsuean Liao; Pau-Yi Huang; Tse-Hua Tan
Journal:  Eur J Immunol       Date:  2011-12-27       Impact factor: 5.532

8.  Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.

Authors:  Crystal Morales Del Valle; Joseph R Maxwell; Maria M Xu; Antoine Menoret; Payal Mittal; Naomi Tsurutani; Adam J Adler; Anthony T Vella
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

9.  Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

Authors:  Abhinav Arneja; Hannah Johnson; Laura Gabrovsek; Douglas A Lauffenburger; Forest M White
Journal:  J Immunol       Date:  2013-12-02       Impact factor: 5.422

10.  Complete response to high-dose IL-2 and enhanced IFNγ+Th17 :  TREG ratio in a melanoma patient.

Authors:  Maggie L Diller; Ragini R Kudchadkar; Keith A Delman; David H Lawson; Mandy L Ford
Journal:  Melanoma Res       Date:  2016-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.